Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma

Graeme J. Poston, H. Daniel Fawcett, Courtney Townsend, Elena James, James L. Lieg, Martin L. Nusynowitz, James C. Thompson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Uptake of 131iodine-metaiodobenzylguanidine (131I-MIBG) by 6-23 rat medullary thyroid carcinoma (MTC), was studied in vitro and in vivo. In vitro, there was an 8-fold increase in 131I uptake by 6-23 cells when labeled with 131I-MIBG (131I 24±15 cpm/106 cells, 131I-MIBG 196±9 cpm/106 cells). MIBG uptake in vitro was the same at 4°C and 37°C. In contrast, (131I-MIBG uptake by PC-12 rat pheochromocytoma cells were 200 times greater (131I-MIBG 42,412±6,755 cpm/106 cells). 131I-MIBG uptake by rat MTC cells in vitro were of a comparable magnitude to the uptake of 131I-MIBG by rat ileal enterochromaffin cells (RIE-1) and mouse colon cancer cells (MC-26). In vivo, uptake of 131I-MIBG by 6-23 MTC tumor was considerably less than in the normal tissues (muscle, liver, spleen, kidney, adrenal and thyroid). Gamma camera studies of 131I-MIBG uptake by 6-23 MTC tumors growing in Wag-Rij rats were only transiently positive in 1 out of 4 rats studied. We conclude that 131I-MIBG is poorly taken up by rat medullary thyroid carcinoma and is an unpredictable marker for localization of rat MTC.

Original languageEnglish (US)
Pages (from-to)1611-1616
Number of pages6
JournalLife Sciences
Volume44
Issue number21
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Rats
Tumors
Enterochromaffin Cells
3-Iodobenzylguanidine
Gamma Cameras
Medullary Thyroid cancer
Reactive ion etching
Pheochromocytoma
Liver
Colonic Neoplasms
Muscle
Neoplasms
Thyroid Gland
Spleen
Cameras
Cells
Tissue
Kidney
Muscles
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology

Cite this

Poston, G. J., Daniel Fawcett, H., Townsend, C., James, E., Lieg, J. L., Nusynowitz, M. L., & Thompson, J. C. (1989). Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma. Life Sciences, 44(21), 1611-1616. https://doi.org/10.1016/0024-3205(89)90456-6

Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma. / Poston, Graeme J.; Daniel Fawcett, H.; Townsend, Courtney; James, Elena; Lieg, James L.; Nusynowitz, Martin L.; Thompson, James C.

In: Life Sciences, Vol. 44, No. 21, 1989, p. 1611-1616.

Research output: Contribution to journalArticle

Poston, GJ, Daniel Fawcett, H, Townsend, C, James, E, Lieg, JL, Nusynowitz, ML & Thompson, JC 1989, 'Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma', Life Sciences, vol. 44, no. 21, pp. 1611-1616. https://doi.org/10.1016/0024-3205(89)90456-6
Poston, Graeme J. ; Daniel Fawcett, H. ; Townsend, Courtney ; James, Elena ; Lieg, James L. ; Nusynowitz, Martin L. ; Thompson, James C. / Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma. In: Life Sciences. 1989 ; Vol. 44, No. 21. pp. 1611-1616.
@article{85027e60d5c743cb95a97a82e94e8aa7,
title = "Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma",
abstract = "Uptake of 131iodine-metaiodobenzylguanidine (131I-MIBG) by 6-23 rat medullary thyroid carcinoma (MTC), was studied in vitro and in vivo. In vitro, there was an 8-fold increase in 131I uptake by 6-23 cells when labeled with 131I-MIBG (131I 24±15 cpm/106 cells, 131I-MIBG 196±9 cpm/106 cells). MIBG uptake in vitro was the same at 4°C and 37°C. In contrast, (131I-MIBG uptake by PC-12 rat pheochromocytoma cells were 200 times greater (131I-MIBG 42,412±6,755 cpm/106 cells). 131I-MIBG uptake by rat MTC cells in vitro were of a comparable magnitude to the uptake of 131I-MIBG by rat ileal enterochromaffin cells (RIE-1) and mouse colon cancer cells (MC-26). In vivo, uptake of 131I-MIBG by 6-23 MTC tumor was considerably less than in the normal tissues (muscle, liver, spleen, kidney, adrenal and thyroid). Gamma camera studies of 131I-MIBG uptake by 6-23 MTC tumors growing in Wag-Rij rats were only transiently positive in 1 out of 4 rats studied. We conclude that 131I-MIBG is poorly taken up by rat medullary thyroid carcinoma and is an unpredictable marker for localization of rat MTC.",
author = "Poston, {Graeme J.} and {Daniel Fawcett}, H. and Courtney Townsend and Elena James and Lieg, {James L.} and Nusynowitz, {Martin L.} and Thompson, {James C.}",
year = "1989",
doi = "10.1016/0024-3205(89)90456-6",
language = "English (US)",
volume = "44",
pages = "1611--1616",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "21",

}

TY - JOUR

T1 - Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma

AU - Poston, Graeme J.

AU - Daniel Fawcett, H.

AU - Townsend, Courtney

AU - James, Elena

AU - Lieg, James L.

AU - Nusynowitz, Martin L.

AU - Thompson, James C.

PY - 1989

Y1 - 1989

N2 - Uptake of 131iodine-metaiodobenzylguanidine (131I-MIBG) by 6-23 rat medullary thyroid carcinoma (MTC), was studied in vitro and in vivo. In vitro, there was an 8-fold increase in 131I uptake by 6-23 cells when labeled with 131I-MIBG (131I 24±15 cpm/106 cells, 131I-MIBG 196±9 cpm/106 cells). MIBG uptake in vitro was the same at 4°C and 37°C. In contrast, (131I-MIBG uptake by PC-12 rat pheochromocytoma cells were 200 times greater (131I-MIBG 42,412±6,755 cpm/106 cells). 131I-MIBG uptake by rat MTC cells in vitro were of a comparable magnitude to the uptake of 131I-MIBG by rat ileal enterochromaffin cells (RIE-1) and mouse colon cancer cells (MC-26). In vivo, uptake of 131I-MIBG by 6-23 MTC tumor was considerably less than in the normal tissues (muscle, liver, spleen, kidney, adrenal and thyroid). Gamma camera studies of 131I-MIBG uptake by 6-23 MTC tumors growing in Wag-Rij rats were only transiently positive in 1 out of 4 rats studied. We conclude that 131I-MIBG is poorly taken up by rat medullary thyroid carcinoma and is an unpredictable marker for localization of rat MTC.

AB - Uptake of 131iodine-metaiodobenzylguanidine (131I-MIBG) by 6-23 rat medullary thyroid carcinoma (MTC), was studied in vitro and in vivo. In vitro, there was an 8-fold increase in 131I uptake by 6-23 cells when labeled with 131I-MIBG (131I 24±15 cpm/106 cells, 131I-MIBG 196±9 cpm/106 cells). MIBG uptake in vitro was the same at 4°C and 37°C. In contrast, (131I-MIBG uptake by PC-12 rat pheochromocytoma cells were 200 times greater (131I-MIBG 42,412±6,755 cpm/106 cells). 131I-MIBG uptake by rat MTC cells in vitro were of a comparable magnitude to the uptake of 131I-MIBG by rat ileal enterochromaffin cells (RIE-1) and mouse colon cancer cells (MC-26). In vivo, uptake of 131I-MIBG by 6-23 MTC tumor was considerably less than in the normal tissues (muscle, liver, spleen, kidney, adrenal and thyroid). Gamma camera studies of 131I-MIBG uptake by 6-23 MTC tumors growing in Wag-Rij rats were only transiently positive in 1 out of 4 rats studied. We conclude that 131I-MIBG is poorly taken up by rat medullary thyroid carcinoma and is an unpredictable marker for localization of rat MTC.

UR - http://www.scopus.com/inward/record.url?scp=0024474402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024474402&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90456-6

DO - 10.1016/0024-3205(89)90456-6

M3 - Article

C2 - 2786600

AN - SCOPUS:0024474402

VL - 44

SP - 1611

EP - 1616

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 21

ER -